BR9810734A - Adesivo para emplastro percutaneamente absorvìvel e emplastro percutaneamente absorvìvel - Google Patents
Adesivo para emplastro percutaneamente absorvìvel e emplastro percutaneamente absorvìvelInfo
- Publication number
- BR9810734A BR9810734A BR9810734-8A BR9810734A BR9810734A BR 9810734 A BR9810734 A BR 9810734A BR 9810734 A BR9810734 A BR 9810734A BR 9810734 A BR9810734 A BR 9810734A
- Authority
- BR
- Brazil
- Prior art keywords
- adhesive
- percutaneously absorbable
- plaster
- crotamiton
- weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
Patente de Invenção: <B>"ADESIVO PARA EMPLASTRO PERCUTANEAMENTE ABSORVìVEL E EMPLASTRO PERCUTANEAMENTE ABSORVìVEL"<D>. Esta invenção apresenta um adesivo para um emplastro percutaneamente absorvível e também um emplastro percutaneamente absorvível que são capazes de conter uma concentração elevada de crotamiton. O adesivo contém crotamiton e pirotiodecano como um compatibilizador e, especialmente, contém de 10 a 40% em peso de um copolímero em bloco elástico de um tipo (A-B)~ n~-A, 10 a 45% em peso de parafina líquida, de 3 a 10% em peso de crotamiton e 0,3 a 10% em peso de pirotiodecano como um compatibilizador para crotamiton. O emplastro compreende o adesivo e a droga.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10244797A JP4073517B2 (ja) | 1997-04-07 | 1997-04-07 | 経皮吸収貼付剤用粘着剤及び経皮吸収貼付剤 |
PCT/JP1998/001409 WO1998044949A1 (fr) | 1997-04-07 | 1998-03-27 | Adhesifs autocollants pour emplatres percutanes et emplatres percutanes |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9810734A true BR9810734A (pt) | 2000-09-12 |
Family
ID=14327733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9810734-8A BR9810734A (pt) | 1997-04-07 | 1998-03-27 | Adesivo para emplastro percutaneamente absorvìvel e emplastro percutaneamente absorvìvel |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1016417A4 (pt) |
JP (1) | JP4073517B2 (pt) |
KR (1) | KR20010006092A (pt) |
CN (1) | CN1252005A (pt) |
BR (1) | BR9810734A (pt) |
CA (1) | CA2284625A1 (pt) |
WO (1) | WO1998044949A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2013081014A1 (ja) * | 2011-11-28 | 2015-04-27 | 株式会社 ケイ・エム トランスダーム | 貼付剤 |
EP3013775A1 (en) | 2013-06-28 | 2016-05-04 | Saudi Basic Industries Corporation | Layered fertilizer composition |
BR112016017496A2 (pt) | 2014-01-29 | 2017-08-08 | Nitto Denko Corp | Composição para acelerar a penetração através da pele, preparação para administração transdérmica e preparação de emplastro de pele |
RU2016134903A (ru) | 2014-01-29 | 2018-03-01 | Нитто Денко Корпорейшн | Композиция для ускорения проникновения через кожу, препарат для трансдермального введения и препарат трансдермального пластыря |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0637463B2 (ja) * | 1986-01-16 | 1994-05-18 | 久光製薬株式会社 | アザシクロアルカン誘導体 |
JP2761542B2 (ja) * | 1989-03-31 | 1998-06-04 | テイカ製薬株式会社 | コルヒチン含有外用製剤 |
US5770221A (en) * | 1994-05-18 | 1998-06-23 | Hisamitsu Pharmaceutical Co., Inc. | Formulation for percutaneous administration for treating disturbance in micturition |
-
1997
- 1997-04-07 JP JP10244797A patent/JP4073517B2/ja not_active Expired - Lifetime
-
1998
- 1998-03-27 EP EP98911070A patent/EP1016417A4/en not_active Withdrawn
- 1998-03-27 BR BR9810734-8A patent/BR9810734A/pt not_active Application Discontinuation
- 1998-03-27 WO PCT/JP1998/001409 patent/WO1998044949A1/ja not_active Application Discontinuation
- 1998-03-27 CA CA002284625A patent/CA2284625A1/en not_active Abandoned
- 1998-03-27 CN CN98803981A patent/CN1252005A/zh active Pending
- 1998-03-27 KR KR1019997009170A patent/KR20010006092A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2284625A1 (en) | 1998-10-15 |
EP1016417A1 (en) | 2000-07-05 |
JP4073517B2 (ja) | 2008-04-09 |
WO1998044949A1 (fr) | 1998-10-15 |
KR20010006092A (ko) | 2001-01-26 |
JPH10279474A (ja) | 1998-10-20 |
EP1016417A4 (en) | 2001-01-17 |
CN1252005A (zh) | 2000-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0510428A (pt) | composições tópicas de metadona e processos para utilização das mesmas | |
BRPI0414313A (pt) | inibidores de citocinas | |
BR0100046A (pt) | Copolìmeros reticulados solúveis em água ou intumescìveis em água | |
BR0209689A (pt) | Uso de fragmento de hmg como agente anti-inflamatório | |
BR0306785A (pt) | Deazapurinas e seus usos | |
DE60231868D1 (de) | Folat-mimetika und deren folatrezeptorbindende konjugate | |
BR0313197A (pt) | Agentes citotóxicos contendo potentes taxanos e seu uso terapêutico | |
BRPI0515012A (pt) | substáncia quìmica, composição e formulação farmacêutica, método de tratamento, método de inibição de pelo menos uma enzima que utiliza atp e uso | |
BRPI0411319A (pt) | compostos terapeuticamente ativos e sua utilização | |
BR0013081A (pt) | Pirimidino-2,4,6-trionas inibidoras de metaloproteinases | |
BRPI0411982A (pt) | glicano de aperfeiçoamento de terapia | |
BRPI0516105A (pt) | composições de fator de crescimento derivado de plaqueta e métodos de uso destas | |
ATE496884T1 (de) | Sulphonylaminoessigsaeure derivate und deren verwendung als orexin rezeptor antagoniste | |
DE60313597D1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
UY27760A1 (es) | Nuevos derivados de pirrolidinio. | |
BRPI0511966A (pt) | composições farmacêuticas contendo polietileno glicol tendo um peso molecular menor do que 600 daltons | |
YU83600A (sh) | Adenozin a3 receptorski modulatori | |
BR9814698A (pt) | Combinação de um inibidor da aldose-redutase com um inibidor do glicogênio-fosforilase | |
BR0111667A (pt) | Novos compostos | |
BR9912073A (pt) | Composições farmacêuticas que compreendem 2-quinolonas | |
ATE335748T1 (de) | Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen | |
SG152257A1 (en) | Topical preparation containing ambroxol | |
BR0003987A (pt) | Composição laxativa | |
EA200500300A1 (ru) | Цитотоксические агенты, содержащие новые сильнодействующие таксаны, и их терапевтическое применение | |
CY1109537T1 (el) | Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DE ACORDO COM O ART 36 DA LPI (LEI 9.279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR. |